Health Canada eyes 140% user fee revenues hike
This article was originally published in Clinica
The Canadian government has unveiled plans to significantly increase user fees for medical devices. Medical technology industry association MEDEC, which is preparing to respond formally to the proposals, says that Health Canada's revenues from the drugs and medical devices industries would increase from Can$47m (US$47m) to Can$112.4m.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.